Nuclear Medicine & Radio Pharmaceuticals Market
Nuclear Medicine & Radio Pharmaceuticals Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth
The global Nuclear Medicine & Radio Pharmaceuticals market is projected to reach a value of $7.2 billion by 2026, with a CAGR of 8.5% during the forecast period. Increasing prevalence of chronic diseases and advancements in nuclear imaging technologies are driving market growth. North America dominates the market. Request
Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ GE Healthcare
◍ Philips Healthcare
◍ Siemens Healthcare
◍ Toshiba
◍ Hitachi
◍ Carestream
◍ Esaote
◍ Shimadzu
◍ TriFoil Imaging
◍ Biosensors International Group, Ltd
The competitive landscape of Nuclear Medicine & Radio Pharmaceuticals Market includes GE Healthcare, Philips Healthcare, Siemens Healthcare, Toshiba, Hitachi, Carestream, Esaote, Shimadzu, TriFoil Imaging, and Biosensors International. These companies utilize nuclear medicine and radio pharmaceuticals for diagnostic imaging and treatment, driving growth in the market. Sales revenue figures: GE Healthcare - $19.8 billion, Siemens Healthcare - $18.1 billion, Philips Healthcare - $11.9 billion.
Request Sample Report
Market Segmentation
By Application
◍ Diagnostic Applications: SPECT, PET.
By Product
◍ Diagnostic Medicine: SPECT
Radiopharmaceuticals, PET
Radiopharmaceuticals
◍ Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
Request Sample Report
$ X Billion USD
Market Growth
Request Sample Report
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients